Pharmaceutical job opportunities: Star recruits for ground-breaking product launch

Star, the UK's first choice outsourcing and resourcing provider to the pharmaceutical, medical device and healthcare industries is delighted to announce a new partnership. Through...

Pf Award Winner & Regional Business Manager at Star, Greg Palin, on building the...

Congratulations on your Pf Award win, how did it feel when your name was announced as winner of the Emerging Talent Award? A shock!...

The Brexit effect: What is happening to the UK science industry?

It’s still impossible to know the full effect of the Brexit referendum on the UK science industry. The vote to leave the European Union...

Manisha Raja, Dermatology Account Manager at LEO Pharma and winner of the Secondary Care...

Congratulations on your Pf Award win Manisha, how did it feel when your name was announced? Thank you! My jaw dropped when my name was...

BD and iTS Leadership demonstrate how honesty and an appetite to solve problems can...

  Tracey Clarke HR Director for UK/Ireland and the Nordic region, BD, on how to create a no-blame culture of continuous learning.   What is BD? BD is a...

Amryt Pharma and University College Dublin unite to bring hope to ‘butterfly children’, who...

Novel gene therapy shows promise Amryt Pharma and University College Dublin unite to bring hope to ‘butterfly children’, who suffer from an incurable skin...

Consilient Health’s Ian Sampson on the importance of traditional sales skills in an evolving...

  More than ever, we are adopting new and innovative ways to communicate, and pharma is no different. Whilst traditional sales skills are just as...

eDetailing: Where are we in 2018?

Words by Dr Andrée Bates Detailing remains a core part of any pharmaceutical company’s sales approach and has become a large part of their promotional...

How can pharma harness the power of data to inform its scientific communications strategy?

Words by Simon Mason Navigating the fast-changing healthcare data landscape is becoming increasingly challenging for pharma, owing to issues such as the rapid growth of...

Latest articles

Image of four people communicating via different mediums to depict mind the Generation Gap in pharma marketing

Mind the Generation Gap in pharma marketing and market research

Industry came together to explore the impact of the generation gap in pharma marketing and market research at BHBIA's summer event. Different generations have always...
AstraZeneca presents results from Phase III TULIP 2 trial for anifrolumab

AstraZeneca presents anifrolumab results from Phase III TULIP trial

Results from the positive Phase III TULIP 2 trial for AstraZeneca's anifrolumab, a potential new medicine for the treatment of moderate to severe systemic...
Scottish flag showing Novartis advanced breast cancer treatment approved in Scotland

Novartis advanced breast cancer treatment approved in Scotland

Novartis’ Kisqali® (ribociclib) in combination with fulvestrant receives recommendation from Scottish Medicines Consortium as advanced breast cancer treatment for patients with the most common...

Popular articles

People sitting around a desk with laptops and tablets to show NHS Commercial Framework for Medicines published for consultation

NHS Commercial Framework for Medicines consultation published

NHS England has published the NHS Commercial Framework for Medicines for consultation. NHS England has a significant role to play in supporting patient access to...
Mapping NHS change is key to customer engagement

Mapping NHS change is key to customer engagement

Simon Grime, of Wilmington Healthcare, explains how mapping NHS change through data and intelligence can help industry understand and engage customers in the new...
Pharmafield logo in lightbulb: Pf Power List 2019

Pf Power List 2019: Who is shaping the pharma & healthcare sector?

The Pf Power List has looked at who is making a difference in pharma and healthcare in 2019. This year has brought a range of developments...
Scottish flag showing Novartis advanced breast cancer treatment approved in Scotland

Novartis advanced breast cancer treatment approved in Scotland

Novartis’ Kisqali® (ribociclib) in combination with fulvestrant receives recommendation from Scottish Medicines Consortium as advanced breast cancer treatment for patients with the most common...
Image of a head with squiggly lines in the brain and cogs on top to indicate Medopad and Janssen collaborate on novel digital biomarker for Alzheimer's disease

Medopad and Janssen collaborate on novel digital biomarker for Alzheimer’s disease

Medopad has announced a strategic collaboration with Janssen Pharmaceuticals, Inc., one of the Janssen Pharmaceutical Companies of Johnson & Johnson, to validate, scale and...

Subscribe

Sign up to receive your free UK subscription to Pf Magazine and our digital newsletters, for all the essential headlines, Jobs of the Week, and thought-provoking features.

Claim my free subscription